Skip to main content
Log in

The inhibitory avoidance test optimized for discovery of cognitive enhancers

  • Measuring Behavior 2008
  • Published:
Behavior Research Methods Aims and scope Submit manuscript

Abstract

In the present article, we describe a new protocol for the inhibitory avoidance test, with a dual purpose: (1) to provide a leß variable and more reliable aßeßment of the efficacy of potential cognitive enhancers in antagonizing scopolamine-induced long-term-memory deficits, and (2) to secure a high throughput for pharmacological screening of cognitive enhancers. The new protocol consists of two acquisition trials that are followed 24 h later by a single retention trial. In the present study, this protocol clearly dißociated the frequency distributions of retention latencies between scopolamine- and vehicle-treated groups and allowed validation by means of two acetylcholinesterase inhibitors—tacrine and donepezil—that proved to be active in counteracting the scopolamine-induced memory deficit. This protocol also produced stability of the behavioral response to pharmacological agents over a 3-year period. A statistical power analysis indicated that, depending on the efficacy of the drug/dose, a sample size of 5–12 mice was required in order to show a reversal of the scopolamineinduced memory deficit. The double-trial acquisition protocol is suitable for testing cognitive enhancers, while also providing a clearly enhanced throughput.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Balogh, S. A., & Wehner, J. M. (2003). Inbred mouse strain differences in the establishment of long-term fear memory. Behavioural Brain Research, 140, 97–106.

    Article  PubMed  Google Scholar 

  • Banfi, S., Cornelli, U., Fonio, W., & Dorigotti, L. (1982). A screening method for substances potentially active on learning and memory. Journal of Pharmacological Methods, 8, 255–263.

    Article  PubMed  Google Scholar 

  • Bartus, R. T., Dean, R. L., Goas, J. A., & Lippa, A. S. (1980). Age-related changes in paßive avoidance retention: Modulation with dietary choline. Science, 209, 301–303.

    Article  PubMed  Google Scholar 

  • Bohdanecký, Z., & Jarvik, M. E. (1967). Impairment of one-trial paßive avoidance learning in mice by scopolamine, scopolamine methylbromide, and physostigmine. International Journal of Neuropharmacology, 6, 217–222.

    Article  PubMed  Google Scholar 

  • Brunner, D., Nestler, E., & Leahy, E. (2002). In need of high-throughput behavioral systems. Drug Discovery Today, 7(18 Suppl.), S107-S112.

    Article  PubMed  Google Scholar 

  • Castellano, C., & Puglisi-Allegra, S. (1983). Strain-dependent modulation of memory by streß in mice. Behavioral & Neural Biology, 38, 133–138.

    Article  Google Scholar 

  • Caulfield, M. P. (1993). Muscarinic receptors—Characterization, coupling and function. Pharmacology & Therapeutics, 58, 319–379.

    Article  Google Scholar 

  • Crawley, J. N., Belknap, J. K., Collins, A., Crabbe, J. C., Frankel, W., Henderson, N., et al. (1997). Behavioral phenotypes of inbred mouse strains: Implications and recommendations for molecular studies. Psychopharmacology, 132, 107–124.

    Article  PubMed  Google Scholar 

  • Dawson, G. R., & Iversen, S. D. (1993). The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory. Behavioural Brain Research, 57, 143–153.

    Article  PubMed  Google Scholar 

  • Dilts, S. L., & Berry, C. A. (1967). Effect of cholinergic drugs on paßive avoidance in the mouse. Journal of Pharmacology & Experimental Therapeutics, 158, 279–285.

    Google Scholar 

  • Ebert, U., & Kirch, W. (1998). Scopolamine model of dementia: Electroencephalogram findings and cognitive performance. European Journal of Clinical Investigation, 28, 944–949.

    Article  PubMed  Google Scholar 

  • Elrod, K., & Buccafusco, J. J. (1988). An evaluation of the mechanism of scopolamine-induced impairment in two paßive avoidance protocols. Pharmacology, Biochemistry, & Behavior, 29, 15–21.

    Article  Google Scholar 

  • Graham, J. H., & Buccafusco, J. J. (2001). Inhibitory avoidance behavior and memory aßeßment. In J. J. Buccafusco (Ed.), Methods of behavior analysis in neuroscience (pp. 141–151). London: CCR.

    Google Scholar 

  • Jarvik, M. E., & Kopp, R. (1967). An improved one-trial paßive avoidance learning situation. Psychological Reports, 21, 221–224.

    Article  PubMed  Google Scholar 

  • Kallman, M. J., & Condie, L. W., Jr. (1985). A test battery for screening behavioral teratogens in mice. Neurobehavioral Toxicology & Teratology, 7, 727–731.

    Google Scholar 

  • Koide, T., Moriwaki, K., Ikeda, K., Niki, H., & Shiroishi, T. (2000). Multi-phenotype behavioral characterization of inbred strains derived from wild stocks of Mus musculus. Mammalian Genome, 8, 664–670.

    Article  Google Scholar 

  • Lamberty, Y., & Gower, A. J. (1990). Age-related changes in spontaneous behavior and learning in NMRI mice from maturity to middle age. Physiology & Behavior, 47, 1137–1144.

    Article  Google Scholar 

  • Pan, S. Y., Han, Y. F., Yu, Z. L., Yang, R., Dong, H., & Ko, K. M. (2006). Evaluation of acute tacrine treatment on paßive-avoidance response, open-field behavior, and toxicity in 17- and 30-day-old mice. Pharmacology, Biochemistry, & Behavior, 85, 50–56.

    Article  Google Scholar 

  • Ray, D., & Nagy, Z. M. (1978). Emerging cholinergic mechanisms and ontogeny of response inhibition in the mouse. Journal of Comparative & Physiological Psychology, 92, 335–349.

    Article  Google Scholar 

  • Rush, D. (1988). Scopolamine amnesia of paßive avoidance: A deficit of information acquisition. Behavioral & Neural Biology, 50, 255–274.

    Article  Google Scholar 

  • Sahgal, A. (1993). Paßive avoidance procedures. In A. Shagal (Ed.), Behavioural neuroscience: A practical approach (Vol. 1, pp. 49–56). New York: Oxford University Preß.

    Google Scholar 

  • Sarter, M., Hagan, J., & Dudchenko, P. (1992). Behavioral screening for cognition enhancers: From indiscriminate to valid testing. Part II. Psychopharmacology, 107, 461–473.

    Article  PubMed  Google Scholar 

  • Saxena, G., Singh, S. P., Agrawal, R., & Nath, C. (2008). Effect of donepezil and tacrine on oxidative streß in intracerebral streptozotocin-induced model of dementia in mice. European Journal of Pharmacology, 581, 283–289.

    Article  PubMed  Google Scholar 

  • Shutske, G. M., Pierrat, F. A., Kapples, K. J., Cornfeldt, M. L., Szewczak, M. R., Huger, F. P., et al. (1989). 9-Amino-1,2,3,4-tetrahydroacridin-1-ols: Synthesis and evaluation as potential Alzheimer’s disease therapeutics. Journal of Medicinal Chemistry, 32, 1805–1813.

    Article  PubMed  Google Scholar 

  • Wehner, J. M., & Balogh, S. A. (2003). Phenotyping mice for learning and memory: Traditional tasks, modifications of traditional tasks, and application of new tasks [Society for Neuroscience, Short course].

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric R. A. Y. Detrait.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Detrait, E.R.A.Y., Hanon, É., Dardenne, B. et al. The inhibitory avoidance test optimized for discovery of cognitive enhancers. Behavior Research Methods 41, 805–811 (2009). https://doi.org/10.3758/BRM.41.3.805

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3758/BRM.41.3.805

Keywords

Navigation